vimarsana.com

Latest Breaking News On - Jacob van naarden - Page 8 : vimarsana.com

Eli Lilly Acquiring Cancer Therapy Developer For $1 4 Billion—A Nearly 90% Premium

American pharmaceutical company Eli Lilly plans to acquire cancer therapy firm Point Biopharma Global, the companies announced Tuesday, an expansion that comes as manu.

United statesEli lillyDavid ricksJacob van naardenPoint biopharma globalVan naardenGlobal oncology trendsLoxo oncology

Eli Lilly Jumps Into Radiopharmaceuticals via $1 4B Point Biopharma Acquisition

Acquiring Point Biopharma gives Eli Lilly a pipeline of radiopharmaceuticals, including one for prostate cancer that could rival Novartis’s Pluvicto. The deal comes ahead of an expected Phase 3 data readout for that Point therapeutic candidate.

New jerseyUnited statesWilliam blairAndy hsiehJacob van naardenNovartis lutatheraEli lillyPoint biopharma globalVan naardenPoint theranosticsMariana oncologyWeight lossMedical devicesHealthcare innovationMedcity newsMedcity news

Lilly buys radiopharmaceutical startup Point Biopharma for $1 4B – Inside INdiana Business

Lilly buys radiopharmaceutical startup Point Biopharma for $1 4B – Inside INdiana Business
insideindianabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insideindianabusiness.com Daily Mail and Mail on Sunday newspapers.

West lafayetteUnited statesJohn russellEli lillyJacob van naardenJoe mccannEndocyte incTherapeutics acquisition corpEli lilly coPoint biopharma global incPoint biopharmaIndianapolis businessTherapeutics acquisitionGeorgetown road

Eli Lilly to Buy Point Biopharma Cancer Treatment Stock Surges 84%

Eli Lilly will acquire radiopharmaceutical company Point Biopharma Global for $12.50 a share.

Jacob van naardenAngela palumboEli lillyPoint biopharmaPoint biopharma globalArticle normalBiotechnology servicesCancer drugsAgricultural machineryHealthcare life sciencesSpecialized drugs medicationsIndustrial goodsOwnership changesAcquisitions mergers shareholdingsAcquisitions mergersCorporate actions

Eli Lilly Buys POINT Biopharma to Boost Its Cancer-Fighting Therapies

Eli Lilly Buys POINT Biopharma to Boost Its Cancer-Fighting Therapies
investopedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investopedia.com Daily Mail and Mail on Sunday newspapers.

Eli lillyJacob van naardenVan naarden

vimarsana © 2020. All Rights Reserved.